Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.01B |
| 2 |
Broadcom
AVGO
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$978M |
| 4 |
JPMorgan Chase
JPM
|
+$714M |
| 5 |
Tesla
TSLA
|
+$626M |
Top Sells
| 1 |
Honeywell
HON
|
+$1.68B |
| 2 |
Visa
V
|
+$1.41B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$855M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$550M |
Sector Composition
| 1 | Technology | 34.36% |
| 2 | Financials | 12.76% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Communication Services | 8.74% |
| 5 | Healthcare | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
iRadimed
IRMD
$907M
| $1.63M | ﹤0.01% |
27,216
+6,501
| +31% | +$389K |
|
2327
Arvinas
ARVN
$568M
| $1.63M | ﹤0.01% |
220,833
+80,964
| +58% | +$596K |
|
|
SNWV
2328
SANUWAVE Health, Inc. Common Stock
SNWV
$317M
| $1.63M | ﹤0.01% |
+49,467
| New | +$1.63M |
|
2329
AdaptHealth
AHCO
$1.26B
| $1.62M | ﹤0.01% |
172,167
+36,310
| +27% | +$342K |
|
2330
Genie Energy
GNE
$404M
| $1.62M | ﹤0.01% |
60,305
+45,500
| +307% | +$1.22M |
|
2331
Ezcorp Inc
EZPW
$1.04B
| $1.62M | ﹤0.01% |
116,764
+34,308
| +42% | +$476K |
|
|
AVDL
2332
Avadel Pharmaceuticals
AVDL
$1.5B
| $1.62M | ﹤0.01% |
182,858
-152,067
| -45% | -$1.35M |
|
2333
Keros Therapeutics
KROS
$636M
| $1.62M | ﹤0.01% |
121,130
+61,270
| +102% | +$818K |
|
2334
Ceco Environmental
CECO
$1.7B
| $1.62M | ﹤0.01% |
57,147
+19,152
| +50% | +$542K |
|
2335
Ramaco Resources Class A
METC
$1.6B
| $1.62M | ﹤0.01% |
122,928
+87,519
| +247% | +$1.15M |
|
2336
Vanguard Dividend Appreciation ETF
VIG
$97.5B
| $1.61M | ﹤0.01% |
7,880
+3,780
| +92% | +$774K |
|
2337
Coupang
CPNG
$59.1B
| $1.61M | ﹤0.01% |
53,747
-382,603
| -88% | -$11.5M |
|
2338
STAAR Surgical
STAA
$1.37B
| $1.61M | ﹤0.01% |
95,929
+12,793
| +15% | +$215K |
|
2339
Allegiant Air
ALGT
$1.19B
| $1.6M | ﹤0.01% |
29,200
-19,113
| -40% | -$1.05M |
|
2340
Hertz
HTZ
$1.99B
| $1.6M | ﹤0.01% |
234,912
-117,111
| -33% | -$800K |
|
2341
Esquire Financial Holdings
ESQ
$828M
| $1.6M | ﹤0.01% |
16,909
+4,423
| +35% | +$419K |
|
2342
BioLife Solutions
BLFS
$1.22B
| $1.6M | ﹤0.01% |
74,029
+25,648
| +53% | +$553K |
|
|
MTSR
2343
Metsera, Inc. Common Stock
MTSR
$3.75B
| $1.6M | ﹤0.01% |
56,091
+36,203
| +182% | +$1.03M |
|
2344
Stoke Therapeutics
STOK
$1.29B
| $1.59M | ﹤0.01% |
139,900
+71,539
| +105% | +$812K |
|
2345
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.4B
| $1.59M | ﹤0.01% |
29,750
| – | – |
|
2346
Gorman-Rupp
GRC
$1.13B
| $1.58M | ﹤0.01% |
43,036
+15,190
| +55% | +$558K |
|
|
BFS
2347
Saul Centers
BFS
$785M
| $1.58M | ﹤0.01% |
46,155
+13,473
| +41% | +$460K |
|
|
CLBR
2348
DELISTED
Colombier Acquisition Corp II
CLBR
| $1.58M | ﹤0.01% |
+101,860
| New | +$1.58M |
|
2349
Merchants Bancorp
MBIN
$1.5B
| $1.58M | ﹤0.01% |
47,643
+25,137
| +112% | +$831K |
|
2350
Jamf
JAMF
$1.41B
| $1.56M | ﹤0.01% |
164,289
+49,940
| +44% | +$475K |
|